# Cesarean Scar Defect Segmentation in Transvaginal Ultrasound Images: a Dataset and Benchmark

arXiv: https://arxiv.org/abs/2605.26774 · HTML: https://mlsanity.com/paper/2605.26774/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 5 of its 21 references that are in the map.
- First posted on arXiv 26 May 2026.

## Builds on (most cited first, 5 of 5)

- [U-Net: Convolutional Networks for Biomedical Image Segmentation](https://mlsanity.com/paper/1505.04597/) (2015)
- [Encoder-Decoder with Atrous Separable Convolution for Semantic Image Segmentation](https://mlsanity.com/paper/1802.02611/) (2018)
- [Swin-Unet: Unet-like Pure Transformer for Medical Image Segmentation](https://mlsanity.com/paper/2105.05537/) (2021)
- [GCNet: Non-local Networks Meet Squeeze-Excitation Networks and Beyond](https://mlsanity.com/paper/1904.11492/) (2019)
- [UniUltra: Interactive Parameter-Efficient SAM2 for Universal Ultrasound Segmentation](https://mlsanity.com/paper/2511.15771/) (2025)

## Abstract (arXiv)

Cesarean Scar Defect (CSD) is one of the most prevalent complications following cesarean delivery. Transvaginal ultrasonography is widely used for primary CSD screening. Accurate determination of CSD outline and dimensions is crucial for treatment. However, CSDs are frequently overlooked by sonographers due to small size and irregular morphology, suboptimal image quality, and limited clinical awareness in resource-constrained settings. Despite artificial intelligence advances in medical imaging, no public dataset exists for transvaginal ultrasound CSD segmentation. To address this gap, we present a comprehensive CSD dataset comprising 1,111 images and 16 videos, yielding 501 positive samples with confirmed CSD and precise pixel-level manual annotations. Annotations are performed following standardized clinical guidelines through collaboration between experienced sonographers and trained PhD students. This work provides high-quality benchmark resources for advancing medical image segmentation algorithms and promoting clinical innovation. Ultimately, improved CSD diagnosis and subsequent treatment strategies can enhance the quality of life in women of reproductive age, representing significant value for both medical research and clinical practice.